# Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer

> **NCT06341309** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **West China Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Irinotecan Liposome
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT06341309
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-09
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06341309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06341309, "Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06341309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*